Article ISI
JOURNAL OF CLINICAL ONCOLOGY  (2022)

Pembrolizumab with or without chemotherapy versus chemotherapy alone for patients with PD-L1-positive advanced gastric or gastroesophageal junction adenocarcinoma: Update from the phase 3 KEYNOTE-062 trial

Lee, Keun Wook; Garrido, Marcelo; Chung, Hyun Cheol Cheol; Castro-Salguero, Hugo Raul

Más información

Título según WOS: Pembrolizumab with or without chemotherapy versus chemotherapy alone for patients with PD-L1-positive advanced gastric or gastroesophageal junction adenocarcinoma: Update from the phase 3 KEYNOTE-062 trial
Título de la Revista: JOURNAL OF CLINICAL ONCOLOGY
Volumen: 40
Número: 4
Editorial: LIPPINCOTT WILLIAMS & WILKINS
Fecha de publicación: 2022
DOI:

10.1200/JCO.2022.40.4_suppl.243
Notas: ISI